862 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B N/A
Article Searches
Shares of Bristol-Myers Falling After Failed Study, While Its Rival Is Surging http://www.zacks.com/stock/news/227117/shares-of-bristol-myers-falling-after-failed-study-while-its-rival-is-surging?cid=CS-ZC-FT-227117 Aug 05, 2016 - Shares of Bristol-Myers were falling in morning trade Friday after one of their drugs didn't reach the levels they were hoping for, while its rival Merck saw its shares climb as its competing drug was more successful in the same trial earlier this year.
Dow 30 Stock Roundup: Merck & Pfizer Earnings Impress; Exxon & Chevron Disappoint http://www.zacks.com/stock/news/227106/dow-30-stock-roundup-merck-pfizer-earnings-impress-exxon-chevron-disappoint?cid=CS-ZC-FT-227106 Aug 05, 2016 - The Dow declined over most of the week but for gains made on Wednesday, weighed down by a number of factors.
BLS Reports Robust July Jobs: 255K, 4.9% Unemployment http://www.zacks.com/stock/news/227064/bls-reports-robust-july-jobs-255k-49-unemployment?cid=CS-ZC-FT-227064 Aug 05, 2016 - Also, May's paltry 11K jobs was more than doubled to 24K, and even June's strong 287K rose another 5000 jobs to 292K.
Immune Design (IMDZ): Stock to Disappoint on Q2 Earnings? http://www.zacks.com/stock/news/226941/immune-design-imdz-stock-to-disappoint-on-q2-earnings?cid=CS-ZC-FT-226941 Aug 04, 2016 - Immune Design Corp. (IMDZ) is scheduled to report second-quarter 2016 results after the market closes on Aug 9.
Pharma ETFs Soaring on Solid Q2 Earnings http://www.zacks.com/stock/news/226660/pharma-etfs-soaring-on-solid-q2-earnings?cid=CS-ZC-FT-226660 Aug 03, 2016 - Pharma ETFs are in focus in the days ahead on impressive Q2 results.
Biogen (BIIB) Stock Surges 8% on Takeover Rumors http://www.zacks.com/stock/news/226424/biogen-biib-stock-surges-8-on-takeover-rumors?cid=CS-ZC-FT-226424 Aug 02, 2016 - Biogen (BIIB) stock jumped 8% on late-afternoon trading on Tuesday on rumors that the company could be bought out by either Allergan (AGN) or Merck (MRK), both large-cap pharmaceutical companies.
Company News for August 01, 2016 http://www.zacks.com/stock/news/226056/company-news-for-august-01-2016?cid=CS-ZC-FT-226056 Aug 01, 2016 - Companies in the News are: XRX,MRK,ABBV,EXPE
What Awaits MNK & Other Drug Stocks this Earnings Season? http://www.zacks.com/stock/news/226043/what-awaits-mnk-other-drug-stocks-this-earnings-season?cid=CS-ZC-FT-226043 Aug 01, 2016 - Let's see what's in store for some medical companies that are expected to declare quarterly numbers on Aug 2.
Merck & Co. (MRK) Kenneth C. Frazier on Q2 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3993254-merck-and-co-mrk-kenneth-c-frazier-q2-2016-results-earnings-call-transcript?source=feed_sector_healthcare Jul 29, 2016 - Merck & Co., Inc. (NYSE:MRK)Q2 2016 Earnings CallJuly 29, 2016 8:00 am ETExecutivesTeri Loxam - Investor Relations ContactKenneth C. Frazier - Chairman, President & Chief Executive OfficerRobert M. Da
Merck (MRK) Updates Outlook Following Q2 Earnings Beat http://www.zacks.com/stock/news/225848/merck-mrk-updates-outlook-following-q2-earnings-beat?cid=CS-ZC-FT-225848 Jul 29, 2016 - Merck (MRK) surpassed Q2 earnings expectations by a penny while revenues were in-line with estimates.

Pages: 1...798081828384858687

<<<Page 84>